background: Dendritic cells (DCs), which are biased toward a tolerogenic profile, play a pivotal role in tissue-remodeling processes and angiogenesis at the maternal -fetal interface. Here, we analyzed the effect of trophoblast cells on the functional profile of DCs to gain insight on the tolerogenic mechanisms underlying the human placental -maternal dialog at early stages of gestation.
Introduction
Several complex interactions between the receptive uterus and the mature blastocyst under hormonal stimulation allow a successful implantation. In this sense, trophoblast antigens and the production of a variety of factors, generally described as blastocyst implantation essential factors, contribute to the induction of a natural tolerogenic maternal response (Chaouat et al., 2010; Yoshinaga, 2010) .
Nowadays, it is well accepted that pregnancy evolves through different immunological stages with a pro-inflammatory or antiinflammatory predominant profile, depending on the stage of gestation analyzed (Mor, 2008; Dekel et al., 2010) . Thus, during the earliest phase of pregnancy, a successful implantation occurs in a regulated pro-inflammatory microenvironment that allows tissue remodeling and angiogenesis at the maternal -placental interface. The following phase is characterized by a shift toward a tolerogenic profile that limits the initial inflammatory response and allows the symbiosis of the placenta and the fetus for fetal growth (Abrahams et al., 2005; Weiss et al., 2009; Mor and Cardenas, 2010) .
The control of the pro/anti-inflammatory microenvirnoment implies several regulatory and tolerogenic mechanisms at the site of fetal antigen exposure, that might operate in a co-ordinated manner to sustain gestation, for example, trophoblast cells: 1-selectively recruit NK CD16
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bright that produce cytokines and growth factors by the secretion of chemokines, 2-activate decidual macrophages in a suppressor and wound healing profile through the phagocytosis of apoptotic trophoblast cells, 3-induce regulatory T cells (Treg CD4 + CD25 + Foxp-3+), 4-express galectins and indoleamine 2, 3-dioxygenase (IDO), among others mechanisms (Aluvihare et al., 2004; Blois et al., 2007; Terness et al., 2007; Leber et al., 2010) . Conventional dendritic cells (DCs) are specialized antigenpresenting cells (Guermonprez et al., 2002; Steinman, 2003; Ardavín et al., 2004 ) with a critical role in the generation of the maternalfetal interface (Laskarin et al., 2007) . In fact, during implantation, the depletion of uterine DCs (uDCs) results in a severe impairment of the implantation process, leading to embryo resorption in allogeneic or syngeneic pregnancies (Pollard, 2008) . Consistent with these observations, using a transgenic mouse model that allows conditional ablation of uDCs, Plaks and colleagues observed an impaired proliferation and differentiation of the decidua, even in the absence of embryos. These changes are associated with disrupted angiogenesis characterized by reduced vascular expansion and attenuated maturation, associated with FMS-like tyrosine kinase 1 and transforming growth factor (TGF)-b1 modulation (Plaks et al., 2008) .
After implantation, the immunoregulatory properties of uDCs are more evident and constitute a complex system of cells that are uniquely able to provide tolerogenic or immunogenic responses. The immune cells in the decidua comprise 1-2% uDCs, and these are scattered through both the decidua basalis (in which trophoblast cells are infiltrated) and the decidua parietalis. Kammerer et al. (2000) described the presence of subpopulations of DCs in decidual tissue during the early phase of human pregnancy, which seem to participate in the protection of the allogeneic fetus in a mouse pregnancy model (Blois et al., 2004; Zarnani et al., 2008) .
Tolerogenic DCs could be characterized by their phenotypic and functional profile (Morelli and Thomson, 2003; Larregina and Morelli, 2006; Reis e Sousa, 2006) . This subpopulation usually expresses low levels of human leukocyte antigen-DR (HLA-DR), CD80 and CD86. Even though DCs could identify pathogenassociated molecular patterns through Toll-like receptors (TLRs), they are resistant to maturation induction by TLR ligands or by signaling through CD40 (Morelli and Thomson, 2007) . Tolerogenic DCs are poor producers of interleukin (IL)-12p70 and tumor necrosis factor-a (TNF-a), but high producers of IL-10 and IDO (Grohmann et al., 2003; Mellor and Munn, 2004) . Tolerogenic DCs are able to induce Tregs expansion while their ability to expand T CD4+ effector cells is impaired (Morelli and Thomson, 2007) .
This specialized Treg population is essential for preventing a maternal immune response against fetal antigens released by trophoblast or fetal cells at the implantation site and in the maternal circulation. Even though distinct phenotypes were described for Tregs, with different cytokine secretion profiles and tissue origin, all of them display suppressive and regulatory properties that contribute to maintaining the antigen-specific T-cell tolerance (Guerin et al., 2009) . In particular, CD4 + CD25 + Foxp-3+ cells induced from CD25 2 precursors in the peripheral tissue and the draining lymph nodes of the uterus (iTregs) are stimulated through antigen-specific or non-specific pathways by tolerogenic uDC (Guerin et al., 2009; Fraccaroli et al., 2009b; Ramhorst et al., 2012) .
In the present work, we investigated modulation of the functional profile of DCs during their interaction with trophoblast cells.
Materials and Methods
Reagents and antibodies
Endotoxin-free reagents and plastic materials were used in all experiments. RPMI-1640 and phosphate-buffered saline (PBS) were purchased from HyClone Laboratories (Logan, UT, USA). Dulbecco's modified Eagle's medium (DMEM) from Gibco (Invitrogen, Argentina). Fetal calf serum (FCS) and penicillin/streptomycin were purchased from Invitrogen Life Technologies (Grand Island, NY, USA). Twenty-four-well flat bottom polystyrene plates and recombinant human IL-4 were from BD Pharmingen (San Diego, CA, USA). Lipopolysaccharide (LPS) from Escherichia coli and recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) were from Sigma-Aldrich (St Louis, MO, USA). Fluorescein isothiocyanate (FITC)-or phycoerythrin (PE)-conjugated anti-CD1a, CD14, CD40, CD83, CD86, HLA-DR and control isotype-matched Abs were from BD Pharmingen.
Blood samples
Blood samples were obtained from fertile women (n ¼ 21) defined as women who had two or more previous normal pregnancies without any miscarriage in their clinical history, non-smokers, who were not under pharmacological treatment for at least 10 days before the day of sampling. Blood was obtained by puncture of the forearm vein, and it was drawn directly into heparinized plastic tubes. Studies with DCs were approved by the 'Academia Nacional de Medicina Review Board' and Ethical Committee. All healthy donors provided written informed consent for sample collection and subsequent analysis.
Generation of human DCs
Peripheral blood mononuclear cells (PBMC) were isolated from blood by Ficoll-Hypaque density gradient centrifugation. CD14+ cells were separated by performing positive selection with CD14+ micromagnetic beads according to the manufacturer's instructions (Miltenyi Biotec., Bergisch Gladbach, Germany). Cell population purity was checked by fluorescence-activated cell sorter (FACS) analysis using anti-CD14 mAb and was found to be .95%. To obtain DCs, monocytes were cultured in RPMI 1640 medium supplemented with 10% FCS, 50 U/ml penicillin, 50 mg/ml streptomycin at 10 6 cells/ml with 20 ng/ml IL-4 and 20 ng/ml GM-CSF.
Co-cultures
Trophoblast cells (Swan-71 cell line, derived by telomerase-mediated transformation of a 7-week cytotrophoblast isolate described by Straszewski-Chavez) (Aplin et al., 2006; Straszewski-Chavez et al., 2009) were cultured in 24-well flat-bottom polystyrene plates in complete DMEM/10% FCS. When the adherent trophoblast cells reached 60% confluence (and .99% viable), 2 × 10 5 cells/well were cultured with or without DCs (4 × 10 5 cells/well) for 24 h in DMEM/10% FCS. Then DCs in suspension were recovered and cultured with or without 100 ng/ml LPS for an additional 24 h. Every culture with DCs was performed in the presence of IL-4 and GM-CSF to maintain their differentiated profile. Then, DCs were used for flow cytometry, ELISA, RT-PCR and suppression and migration assays.
To obtain conditioned media (CM), adherent Swan-71 cells were cultured in T25 flasks in complete DMEM/2% FCS overnight. Supernatants were collected and frozen at 2808C until use. As an additional control, we quantified RNA in the CM to show that adherent trophoblast cells were not removed during the collection procedure of DCs. The RNA levels in the CM were below the detection limit indicating that trophoblast cells remain adherent to the plate.
Dendritic cell conditioning by trophoblast cells
Flow cytometry analysis
Cells were stained with the following mAbs: FITC-or PE-conjugated mAbs anti CD1a, CD14, CD40, CD83, CD86 and HLA-DR. Ten thousand events were acquired in an FACS Calibur w cytometer and results were analyzed using CellQuest software (BD Biosciences, San Jose, CA, USA).
Intracellular staining for Foxp3 detection
Flow cytometry analyses were performed according to the manufacturer's instructions (Human Regulatory T cell staining kit, eBioscience, San Diego, CA, USA). Briefly, 1 × 10 6 cells were stained with a CD4/CD25 cocktail.
After 30 min, cells were washed with staining buffer and then incubated with the fixation/permeabilization buffer for an hour. After washing, nonspecific sites were blocked by adding 2 ml (2% final) normal rat serum, in 100 ml for 15 min. Then cells were incubated with the anti-human Foxp3 (PCH101) antibody or rat immunoglobulin G2a isotype control for at least 30 min at 48C. Finally, cells were washed with permeabilization buffer and analyzed in a flow cytometer FACSArias w .
Suppression assays
DCs were pre-cultured with or without trophoblast cells for 24 h and some were then treated with LPS (100 ng/ml) for an additional 24 h. Then, DCs (3 × 10 4 cells/well) were treated with mitomycin C (0.5 ng/ 
Measurement of cytokine production
DCs were grown with or without trophoblast cells for 24 h at 378C, and then for a further 24 h with or without 100 ng/ml LPS, as above. Then, culture supernatants were collected, and analyzed for the presence of IL-6, IL-8, IL-10, IL-12p70, monocyte chemotactic peptide (MCP)-1 and TNF-a by ELISA performed according to the manufacturer's instructions (R&D System, MN, USA).
RT-PCR for IDO detection
Determination of IDO was performed by RT-PCR. Briefly, total RNA was isolated following the manufacturer's recommendations using Trizol reagent (Life Technologies), and cDNAs were generated using a commercial kit (Clontech, Palo Alto, CA, USA) and stored at 2208C for batched analyses. The sample volume was increased to 25 ml and contained 50 mM KCl; 10 mM Tris (pH 8.3); 1.5 mM MgCl 2 ; 0.1 mM forward (5 ′ -GGCTGGAAAGGCAACCCCCA-3 ′ ) and reverse (5 ′ -GCAGCA TGTCCTCCACCAGCA-3 ′ ) primers and 1 U Taq polymerase, and the reaction carried out in a DNA Thermocycler (PerkinElmer/Cetus, Boston, MA, USA). The primers and the thermal profile were selected with PrimerBlast software (www.ncbi.nlm.nih.gov/tools/primer-blast/). After an initial denaturation step at 948C for 5 min, we used a denaturation step at 958C for 30 s, an annealing step at 628C for 30 s and an elongation step at 728C for 30 s, for a total of 35 cycles. A final extension step at 728C for 10 min was carried out. PCR products (161 bp for IDO) were electrophoresed through a 2% ethidium bromide-stained agarose gel, 
Migration assays
Assays for the migration of cells across polycarbonate membranes were performed as previously described (Bleul et al., 1996) . DCs were resuspended in DMEM/2% FCS with 20 ng/ml IL-4 and 20 ng/ml GM-CSF. 2 × 10 5 cells were placed in the upper chamber of a 6.5 mm diameter
Transwell culture insert (Costar, Corning Incorporated, NY, USA) with a pore size of 5 mm. The lower chamber of each well contained 600 ml of DMEM/2% FCS, with 20 ng/ml IL-4 and 20 ng/ml GM-CSF or CM supplemented with 20 ng/ml IL-4 and 20 ng/ml GM-CSF. After incubation for 4 h at 378C, the contents of the lower chamber were recovered and migrating cells were counted with an FACS Calibur.
Endocytosis of FITC-conjugated ovoalbumin
DCs were suspended at 5 × 10 5 cells/ml in RPMI/10% FCS. FITCconjugated ovoalbumin (FITC-OVA) was added at a final concentration of 100 mg/ml, and cells were incubated for 30 min at 378C. Cells were then washed three times with cold PBS containing 1% FCS and were analyzed by FACS as previously described. The fluorescence background (cells incubated with FITC-OVA at 48C) was subtracted. We used the dye trypan blue to quench extracellular fluorescence, as described (Sahlin et al., 1983; Van Strijp et al., 1989) . Endocytosis assays were performed as previously indicated and the acquisition of samples was performed in the presence of 200 g/ml trypan blue.
Statistical analysis
Statistical significance was determined using one-way analysis of variance for multiple comparisons with Bonferroni post-test or Student's t-test. Statistical significance was defined as P , 0.05, using the GraphPad Prism4 software (GraphPad, San Diego, CA, USA).
Results
Trophoblast cells prevent the up-regulation of CD83 expression in DCs stimulated by LPS
DCs were co-cultured with trophoblast cells and stimulated with LPS as described above and then the expression of HLA-DR, CD86, CD40 and CD83 was evaluated. As shown in Fig. 1A , FACS analysis revealed that trophoblast cells significantly impaired the up-regulation of CD83 expression triggered by LPS without affecting the expression of CD86, CD40 and HLA-DR (Fig. 1A) . Trophoblast cells do not express HLA-DR, CD86, CD40 and CD83 (data not shown). Figure 1B shows representative histograms for the expression of CD83, CD86, CD40 and HLA-DR.
Trophoblast cells modulate the production of cytokines by DCs
Then, we investigated the cytokine profile of DCs cultured with or without trophoblast cells for 24 h and then stimulated with LPS for another 24 h. Figure 2 shows that trophoblast cells stimulated the production of IL-10 by DCs and further increased the production of IL-10 
Dendritic cell conditioning by trophoblast cells by LPS-treated DCs. In contrast, trophoblast cells markedly impaired the production of IL-12p70 and TNF-a by LPS-treated DCs but induced a significant increase in IL-8 production in LPS-treated DCs.
On the other hand, we observed no modulation of IL-6 and MCP-1 by trophoblast cells under these conditions. Trophoblast cells were cultured in the presence of IL-4 and GM-CSF, as DCs, and we did not observe any modulation in the secretion of any of the tested cytokines (data not shown).
Trophoblast cells condition DCs to display a suppressor profile
We next analyzed the ability of DCs to suppress allogeneic response and to increase IDO expression. As depicted in Fig. 3A , DCs precultured with trophoblast cells and challenged with LPS were able to significantly suppress the allogeneic response in comparison with those DCs that had not interacted with trophoblast cells. Interestingly, this effect was accompanied by a significant increase in IDO expression (Fig. 3B) . As an additional control, Swan-71 cells were tested and resulted negative for IDO expression (Fig. 3B) . Finally, DCs cultured with trophoblast cells maintained their endocytic properties, as evaluated by FACS (Fig. 3C) . Taken together, these results suggest that trophoblast cells promote the differentiation of DCs into a tolerogenic profile based on their phenotype, suppressor ability and the increase in IDO expression, and they maintained their endocytic activity.
Trophoblast cells instruct DCs to induce Tregs
As we mentioned previously, tolerogenic DC have the ability to induce Tregs and then regulate the immune response, promoting a tolerogenic response. Since human CD4 + CD25+ regulatory T cells mediate feto-maternal tolerance, we focused on the ability of DC, after the interaction with trophoblast cells, to induce maternal Tregs leading to immune tolerance. As depicted in Fig. 4A , the frequency of CD4 + CD25 + Foxp3+ cells significantly increased in the presence of DCs pre-cultured with trophoblast cells in comparison with cultures performed with DCs without interaction with trophoblast cells. Moreover, the CM from trophoblast cells (Swan CM) also induced Tregs, although this difference was not significant. As an additional control, we also evaluated the frequency of CD4 + CD25 + Foxp3+ in co-cultures of PBMCs and DCs stimulated with LPS and we observed a significant reduction in Tregs induction. Finally, the medium used for DC differentiation was unable to induce Tregs. Figure 4B shows representative dot plots of independent samples.
Trophoblast cells stimulate the migration of DCs
Finally, we analyzed whether trophoblast cells could induce the migration of DCs. As depicted in Fig. 5 , CM from trophoblast cells significantly stimulated the migration of DCs to the lower chamber compared with the migration observed in the presence of medium.
Discussion
The results presented here provide experimental evidence that DCs display a tolerogenic profile after the interaction with trophoblast cells, particularly after they were challenged with LPS. Our conclusions are based on different observations obtained from an in vitro model that represents the interaction between trophoblast Swan-71 cells and DCs obtained from CD14+ purified cells from fertile women. Trophoblast cells impaired the up-regulation of CD83 expression triggered by LPS and suppressed the production of IL-12p70 and TNF-a stimulated by LPS while they enhanced the production of IL-10 by DCs stimulated, or not, with LPS. This functional phenotype of DCs was associated with a suppressor effect on the allogeneic response, Figure 2 Trophoblast cells modulate the production of cytokines by DCs. DCs were cultured with or without trophoblast cells for 24 h and then stimulated with 100 ng/ml LPS. After 24 h, supernatants were recovered and cytokine production was evaluated by enzyme-linked immunosorbent assay. Results are expressed in pg/ml and represent mean + SEM of six experiments (*P , 0.05).
increased IDO production and maintenance of endocytic properties. Moreover, those DCs that interacted with trophoblast cells were able to induce an increase in the frequency of CD4 + CD25 + Foxp3+, while this modulation was not observed in cultures performed with DCs without trophoblast interaction. Finally, trophoblast cells appeared to be responsible for recruiting DCs, as shown by a significant increase in the frequency of DCs that migrated in response to CM from Swan-71 cells.
The effect that trophoblast cells impose on DCs might involve an alternative activation pattern in DCs. DCs with the ability to induce tolerance may need to be resistant to maturation-inducing factors and, in our in vitro model, they acquired a functional profile compatible with a suppressor-tolerogenic profile. These data agree with previous reports showing a differential response to TLRs at the maternal-fetal interface. As an example, the stimulation of TLR4 by LPS in first trimester trophoblast cells induces a slow inflammatory response, characterized by a modest up-regulation of pro-inflammatory cytokines (Abrahams et al., 2004; Koga et al., 2009) .
In addition, uterine epithelial cells produce factors that regulate DC depending on the stage of pregnancy from the periconceptual period to the post-implantation stage, as recently shown for GM-CSF (Moldenhauer et al., 2010). The co-culture model of the maternal-placental interaction used here could also depict the variable pattern of cell-to-cell interaction, however, it seems to mainly represent the post-implantation period when the suppressor response is predominant (Fraccaroli et al., 2009b; Ramhorst et al., 2012) .
Signaling through the inhibitory immunoglobulin-like transcript 4 (ILT4) receptor in human DCs impairs their maturation in vitro (Liang and Horuzsko, 2003) . On the other hand, non-classical HLA-G, the natural ligand of ILT4 expressed by trophoblast cells (Proll et al., 1999) , may modulate cytokine secretion from DCs, promoting the development of tolerogenic human monocyte-derived DCs in vitro. Specifically, the arrest of maturation of ILT4-positive DCs by HLA-G ligands involves the IL-6 signaling pathway and STAT3 activation (Liang et al., 2008) , which is a main cytokine for a successful implantation (Simhan et al., 2008) . Moreover, DC differentiation by ILT4 and HLA-G induces Type 1 regulatory T cells through an IL-10-dependent pathway, which suppresses immune responses in vivo and in vitro and plays a key role in maintaining tolerance to self-and non-self-antigens (Gregori et al., 2010) . In this sense, Swan-71 cells produce several soluble factors, such as TGF-b, that contribute to the generation and maintenance of the maternal -placental unit and might contribute to an adequate microenvironment to induce tolerogenic DCs or several chemokines that are involved in the recruitment of DCs (Ramhorst et al., 2012) . An additional marker for tolerogenic DCs is IDO production. This intracellular enzyme is constitutively active at the maternal -placental interface. The pharmacological inhibitor of IDO (1-methyl-tryptophan) was used to inhibit IDO activity in pregnant mice, and resulted in the rejection of allogeneic fetuses (Munn et al., 1998) . Not only human extravillous trophoblast cells express IDO (Munn et al., 1998) , but also tolerogenic DC might represent an additional source of IDO. Here, we clearly observed an increase in IDO expression in DCs cultured with trophoblast cells. The expression of IDO was associated with a reduced ability of LPS-triggered DCs to mediate an allogeneic response. These data agree with previous results showing that the over-expression of IDO results in immunosuppression and tolerance, as IDO-transfected cell lines suppressed antigen-specific T cell responses in vitro (Mellor et al., 2002) .
As the fetus and placenta are semi-allogeneic to the mother, the abnormal induction of tolerogenic-DCs might be implicated in pregnancy complications. In this sense, it was previously reported that patients with recurrent spontaneous abortions might have an altered mechanism allowing the survival of T cells activated by fetal antigens, which could compromise the success of pregnancy (Fraccaroli et al., 2009a (Fraccaroli et al., , 2010 . Even though several immunological factors have been postulated to play a role in the etiology of recurrent abortion, potent immunostimulatory (CD83+) DCs have been identified in the decidua from women with recurrent miscarriage at 8 weeks of gestation, which contained more DCs than gestational age-matched normal controls (Askelund et al., 2004) .
Finally, CD4 + CD25+ T cells comprising the expanded pool in pregnancy are highly enriched in Foxp3 and exert a suppressive function in vitro (Somerset et al., 2004) . Recently, Guerin et al. (2009) proposed a working model of the key steps in the induction and effector pathways of Treg cell activation, expansion and suppressive function to mediate maternal -fetal tolerance by tolerogenic DCs. In a first step, seminal fluid elicits an inflammation-like response in the female reproductive tract associated with recruitment of DCs into the endometrial and cervical tissues (Robertson et al., 2002) . Then, paternal antigens (seminal fluid shares many of the paternal antigens later expressed by the conceptus) are processed within tolerogenic DCs and activate T-cells in draining lymph nodes from the uterus. Finally, the iTreg cells are recruited from the maternal circulation into the decidual tissue, mediated by specific patterns of chemokines. After implantation, trophoblast cells produce high levels of TGF-b (Ramhorst et al., 2012) , and here we show that trophoblast cells also condition the DC profile toward a tolerogenic one, skewing the T-cell response toward a Treg cell phenotype.
Although researchers have investigated the mechanisms leading to immune tolerance during the past decade, the particular cellular and molecular mechanisms underlying embryo-uterine interactions remain unclear. Results presented here provide experimental evidence that trophoblast cells, the physiological unit of the placenta, can induce a tolerogenic profile in DCs that contributes to limiting the pro-inflammatory response in the early stages of pregnancy.
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